Roivant (ROIV) Director Keith S. Manchester Receives Awards

What Happened

• Keith S. Manchester, a director of Roivant Sciences Ltd. (ROIV), was granted two equity awards on 2026-09-16: 5,054 restricted stock units (RSUs) and 10,531 stock options. Both awards are reported as acquired at $0 (standard for grants), so no cash changed hands.

Key Details

• Transaction date: 2026-09-16; Form 4 filed: 2026-09-18 (appears timely).
• RSUs: 5,054 shares granted; reported value $0 on grant. Vesting: 100% on September 16, 2027, subject to continued service (Footnote F1).
• Stock options: 10,531 options granted (derivative transaction); reported value $0 on grant. Options vest and become exercisable 100% on September 16, 2027, subject to continued service (Footnote F2).
• Shares owned after transaction: not stated in the provided excerpt.
• Exhibit 24 (Power of Attorney) included on the filing.

Context

• These are grants (compensation), not purchases or sales. RSUs convert to shares on vesting; options provide the right to buy shares in the future if exercised. Neither award was exercised or sold here, so this filing does not reflect immediate market buying or selling.
• Such annual director awards are routine and tied to service; they do not necessarily indicate the director’s near-term trading intentions.